Feline inflammatory bowel disease
| Autor: | M. Staniec, E. Pyzik, Diana Stęgierska, Andrzej Puchalski, Renata Urban-Chmiel, A. Łojszczyk |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
General Veterinary medicine.diagnostic_test medicine.drug_class business.industry Antibiotics Inflammation medicine.disease Antiparasitic agent Inflammatory bowel disease Gastroenterology Pathogenesis Pharmacotherapy Internal medicine Biopsy medicine Histopathology medicine.symptom business |
| Zdroj: | Medycyna Weterynaryjna. 75:6293-2019 |
| ISSN: | 0025-8628 |
| DOI: | 10.21521/mw.6293 |
| Popis: | Inflammatory bowel disease (IBD) is one of the most common causes of chronic clinical signs from the gastrointestinal tract, associated with histological evidence of inflammation in the lamina propria of the small and/or large intestine in cats. The underlying etiopathogenesis of this inflammation remains unclear. IBD is probably caused by a combination of environmental and immune factors in genetically susceptible individuals. The process of diagnosing IBD involves several steps and is based on the exclusion of other causes of gastrointestinal signs and on the confirmation of the presence of inflammatory infiltration in the intestinal wall by histopathological assessment of biopsies. The treatment is based on anti-inflammatory and immunosuppressive drugs. In addition, dietotherapy, antibiotics, antiparasitic drugs, prebiotics, probiotics and supplementation of vitamin b12 are also used. For most patients, the response to treatment is satisfactory, but the maintenance of clinical remission in most of them may require anti-inflammatory drugs for the rest of their lives. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|